
Does Biologic Treatment in Psoriasis Reduce the Risk of PsA?
Retrospective claims analysis shows that psoriasis patients treated with an IL-12/23 inhibitor or an IL-23 inhibitor had a lower risk of developing incident PsA.
https://t.co/j73V7zMnkn https://t.co/EhGUXDNNlS
Links:
09-03-2023